BioSpace News Archive

AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers.

Eiger BioPharmaceuticals, Inc. today announced that David Cory , President and Chief Executive Officer of Eiger, will present a corporate update at the Ladenburg Thalman 2021 Virtual Conference.

Solstice Pharmaceuticals has successfully completed its latest round of funding to further the clinical development of its innovative ultrasound contrast agent (UCA).

Xenon Pharmaceuticals Inc. today provided an update on its ongoing XEN1101 Phase 2b “X-TOLE” clinical trial, announcing that randomization of 326 patients was completed in late June.

Neurana Pharmaceuticals today announced the publication of a manuscript, “RESUME-1: A Phase III Study of Tolperisone in Treatment of Painful, Acute Muscle Spasms of the Back” in the journal of “Pain Management”.

It is tricky to present your best impression in an interview because of difficult questions. So, practice these sample interview questions and answer to give the best impression.

Bold Therapeutics is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug Application (IND) amendment for BOLD-100-001'

OpSens Inc. will report financial results for its third quarter of fiscal year 2021, ended May 31, 2021, on Tuesday, July 13, 2021, before the open of the market.

Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer; Karen E. Nelson joins the company as new CSO. [07-July-2021] WALTHAM, Mass. , July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has serve